Axogen Inc vs Global X Defense Tech ETF — how do they compare? Axogen Inc trades at $38.5 (market cap $2.06B), while Global X Defense Tech ETF trades at $60.31. The key difference: Axogen Inc is trading nearer its 52-week high, Global X Defense Tech ETF nearer its low. Which is the better fit depends on your goals.
| AXGN | SHLD | |
|---|---|---|
Market Cap | $2.06B | — |
Sector | Technology | Sector/Thematic |
52-Week High | $46.19 | $78.02 |
52-Week Low | $11.28 | $58.20 |
Enterprise Value | $1.98B | — |
Signals from Pluang's Aura AI — not financial advice
AXGN trades at $39.49, down 2.69% today, with a bearish technical signal despite recent earnings volatility. The company reported mixed quarterly results with Q3 2025 beating estimates but Q1 2026 missing expectations. Strong analyst sentiment persists with 84% buy ratings and a $47.60 consensus price target, though negative profit margins and recent technical weakness create uncertainty.
The outlook remains cautiously optimistic given strong institutional support and reimbursement progress, but investors face risks from persistent losses and competitive pressures. The stock's current position near support at $39 suggests potential for recovery if upcoming Q2 earnings meet or exceed the $0.09 EPS estimate.
SHLD (Global X Defense Tech ETF) trades at $60.47, down 1.18% today amid bearish technical signals. The ETF faces selling pressure with moving averages indicating a downtrend, though oscillators remain neutral. Recent news highlights defense sector opportunities from global military spending increases and geopolitical tensions, with SHLD positioned as a diversified play on defense technology innovation across international markets.
Outlook remains mixed with technical weakness offset by positive sector catalysts. Investment opportunity lies in exposure to rising global defense budgets and technological modernization, but risks include political uncertainty and competition from specialized ETFs. The bearish technical setup suggests cautious entry points near support levels may be prudent for long-term investors.
Trailing returns across standard periods
Latest headlines on both assets
Axogen is a leader in peripheral nerve regeneration and repair. It provides innovative surgical solutions and clinically proven products, like nerve grafts, to help restore function and quality of life for patients.
Read more on AXGN →SHLD tracks the Global X Defense Tech Index, targeting companies that lead the technological transformation of the defense sector. It focuses on pure-play innovators in cybersecurity, artificial intelligence, robotics, and advanced military systems, excluding traditional commercial aerospace to maintain a high level of thematic purity.
Read more on SHLD →